Skip to main content
Premium Trial:

Request an Annual Quote

Opossum Change

Researchers have edited the opossum genome, a task made more difficult due to the complicated reproductive biology of marsupials, MIT's Technology Review reports.

A Riken-led team used CRISPR/Cas9 to target the Tyrosinase (Tyr) gene in pronuclear-stage zygotes from the gray short-tailed opossum Monodelphis domestica. If one allele was successfully disrupted, the resulting opossum would be mosaic and if both alleles were disrupted, then it would be albino, Tech Review adds. As the researchers report in Current Biology, they generated five albinos, two mosaic, and eight wild-type coat color opossums with genome-edited alleles. Additionally, they crossed mosaic female opossums with male albino ones to confirm germline transmission.

As Tech Review notes, the researchers also had to contend with the difficulties posed by opossum reproduction and had to coax the animals to mate later in the day so that they could then inject the CRISPR machinery before a coating around the eggs became too hard.

"I think it's an incredible result," the University of Texas' Richard Behringer tells Tech Review, adding that "[t]hey've shown it can be done. Now it's time to do the biology."

The Scan

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.

Study Reveals Potential Sex-Specific Role for Noncoding RNA in Depression

A long, noncoding RNA called FEDORA appears to be a sex-specific regulator of major depressive disorder, affecting more women, researchers report in Science Advances.

New mRNA Vaccines Offer Hope for Fighting Malaria

A George Washington University-led team has developed mRNA vaccines for malaria that appear to provide protection in mice, as they report in NPJ Vaccines.

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.